NanoNeurosciences was founded on a mission to redefine the treatment of glaucoma and neurodegenerative ocular diseases. Witnessing the profound impact of glaucoma on our loved ones fueled our determination to actively seek transformative solutions. We’re not just searching for better treatments; we are pioneering a paradigm shift that goes beyond symptom relief to the possibility of restoring vision entirely.
Founded in early 2024, NanoNeurosciences is pioneering a new era of glaucoma treatment through advanced nanomedicines. Our research is centered around developing a low-cost, biocompatible, drug-free, and tissue-specific therapy that targets the root causes of ocular degeneration — not just the symptoms.
Since May 2024, NanoNeurosciences operates out of UF Innovate | Sid Martin Biotech in Alachua, Florida — one of the nation’s leading biotech incubators. Here, we are harnessing the latest developments in nanoengineering and neural regeneration to push the boundaries of what is possible.
We’re not just imagining a world where glaucoma no longer exists, we’re engineering it.
At NanoNeurosciences, innovation is driven by the relentless passion and expertise of our multidisciplinary team. Our scientific co-founders are pioneers in their fields, blending world-class knowledge to push the boundaries of glaucoma treatment and neurodegenerative disease research.
Co-Founder & Chief Executive Officer
Co-Founder & Chief Scientific Officer
Our groundbreaking science is propelled forward by a leadership team with the business acumen to turn innovation into global impact.
Co-Founder & Chairman, Healthcare Management Strategist
Co-Founder & Chief Financial Officer
Cell & Gene Therapy Industry Pioneer & GMP Expert
Precision Medicine GTM Strategist, Omics Integration
EOS Implementer
Research Professor in Pharmacology, School of Medicine, Vanderbilt University.
NanoNeurosciences, Inc.
UF Innovate at Sid Martin Biotech, 12085 Research Dr., Lab 130, Alachua, FL 32615, USA
Copyright © 2025 by NanoNeurosciences, Inc.
